Metraipolis › archive › dc_ba4e027fa18d

Tolerability and adherence to adjuvant abemaciclib in hormone receptor-positive, HER2-negative, node-positive high-risk early breast cancer: a real-world study — Europe PMC PMID:42684120

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42684120
DOI
10.2340/1651-226x.2026.45961
License (as archived)
solo-consultazione
Archived
2026-10-16T05:20:51.557Z
SHA-256 of the archived text
ca79ea91c6d6a19c037760b9c15e1317138700fcb6e529eb0f6be7739cc6139b
Stable URL of this page
https://metraipolis.com/documento/dc_ba4e027fa18d

How to cite

Tolerability and adherence to adjuvant abemaciclib in hormone receptor-positive, HER2-negative, node-positive high-risk early breast cancer: a real-world study — Europe PMC PMID:42684120 — Europe PMC (en), https://europepmc.org/article/MED/42684120 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ba4e027fa18d (Metraipolis archive dc_ba4e027fa18d, sha256 ca79ea91c6d6a19c037760b9c15e1317138700fcb6e529eb0f6be7739cc6139b)
BibTeX
@misc{dcba4e027fa18d,
  title = {Tolerability and adherence to adjuvant abemaciclib in hormone receptor-positive, HER2-negative, node-positive high-risk early breast cancer: a real-world study — Europe PMC PMID:42684120},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42684120},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ba4e027fa18d; sha256 ca79ea91c6d6a19c037760b9c15e1317138700fcb6e529eb0f6be7739cc6139b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42684120. Agents can read the archived copy with the MCP tool read_document.